Search - tctmd.com

Displaying 601 - 620 of 1103

Sort: Relevancy | Date

Signal of Aortic Stenosis Risk With Celecoxib

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

February 27, 2019

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

News Daily News

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

Michael O'Riordan

February 26, 2019

Quality of CAD Care Varies by Type of Medicare Coverage

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

February 20, 2019

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

February 15, 2019

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

News Daily News

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

February 12, 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

News Conference News ISC 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

February 12, 2019

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND

News Daily News

Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND

February 04, 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

News Daily News

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

January 24, 2019

Bias Over Knowledge: Whether Patients Get Guideline-Recommended Statins Depends on Physician Beliefs

News Daily News

Bias Over Knowledge: Whether Patients Get Guideline-Recommended Statins Depends on Physician Beliefs

Yael L. Maxwell

January 10, 2019

Flu Tied to Worse Outcomes in Patients Hospitalized With Heart Failure

News Daily News

Flu Tied to Worse Outcomes in Patients Hospitalized With Heart Failure

January 03, 2019

Top News in Prevention: 2018

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering for Almost All Patients

News Daily News

FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering

Yael L. Maxwell

December 19, 2018

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

December 18, 2018

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

News Daily News

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Michael O'Riordan

December 10, 2018

CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden

News Conference News WCC 2018

CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden

December 06, 2018

NOACs Significantly Curb Risk of VTE in Cancer Patients

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

December 06, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.